ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is a diversified biopharmaceutical company that develops, manufactures, and markets high-quality branded and generic prescription pharmaceutical products. The team focuses on sustainable growth by scaling up their Rare Disease business, enhancing their generics business, and leveraging North American manufacturing capabilities.
